CClinicalTrials.gg
TerminatedNCT05084274Updated Mar 15, 2024

Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program

An interventional study of Lifestyle program in Infertility, Female, Polycystic Ovarian Syndrome and Lifestyle, sponsored by Universitair Ziekenhuis Brussel. Terminated at 1 site in Belgium. Open to female participants aged 18 Years to 38 Years. Per ClinicalTrials.gov, last updated 2024-03-15.

Sponsored by Universitair Ziekenhuis Brussel · Not applicable, Interventional, and Treatment

Why this study was terminated
Co-investigators have left and not been replaced.
Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Randomized
Ages
18 Years to 38 Years
Sex
Female
01

Study summary

Patients will be randomly assigned to a group where they undergo a 12-week lifestyle modification program prior to their fertility treatment, or a group where they are entitled to start their fertility treatment without prior lifestyle modification program.

Read the detailed description

When allocated to the control arm patients will receive the standard of care combined with the foreseen questionnaires and bio-electric impedance analysis for body composition and ergospirometry. When the patient is allocated to the interventional arm she will receive a 12-week lifestyle modification program prior to her fertility treatment. The lifestyle modification program will consist of dietary advice, advice for physical activity and emotional support. After the 12-week program the fertilty treatment will start as per routine practice. Questionnaires, ergospirometry and bio-electric impedance analysis will also be performed at the foreseen moments.

02

Conditions studied

  • Infertility, Female
  • Polycystic Ovarian Syndrome
  • Lifestyle
03

In context

Polycystic Ovary Syndrome

944 studies on the registry are indexed under Polycystic Ovary Syndrome; 174 are open to participants now.

This study's enrollment of 19 is below the median of 70 across 685 interventional studies indexed under Polycystic Ovary Syndrome.

Browse Polycystic Ovary Syndrome studies →

Lead sponsor

Universitair Ziekenhuis Brussel is the lead sponsor of 362 studies on the registry; 103 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 38 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Subfertile patients between >18- \<38 years old requesting fertility treatment at our centre
  • PCOS phenotypes A, B, C and D according to the NIH 2012 extension of the ESHRE/ASRM 2003 diagnostic criteria
  • BMI >27 and \<38 (Jiskoot et al. 2017)
  • Nulliparous women
  • Patient gives consent voluntarily

Exclusion criteria

Exclusion Criteria:

Patients will be excluded if they:

  • do not meet the ESHRE/ASRM 2003 diagnostic PCOS criteria
  • Have a BMI \<27 and >38 (Jiskoot et al. 2017)
  • Need Surgical sperm retrieval
  • Use donor eggs
  • Need Pre-implantation genetic testing (PGT)
  • Multiparous women
  • cannot reliably fill out the questionnaires or comprehend the intervention, because of a language barrier
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
19 participants (actual)

Study arms

  • Active comparator
    Lifestyle intervention group

    12-week lifestyle modification programme through face-to-face lifestyle counseling and physiotherapy combined with a follow-up programme using video consultations and online training sessions

    Behavioral: Lifestyle program

  • No intervention
    Standard-of-care group

    No intervention

Interventions

  • BehavioralLifestyle program

    If the patient is allocated to the interventional group, the lifestyle modification program will be planned/started immediately after the intake at the fertility clinic. The lifestyle modification program has a duration of 12 weeks in which the subject will receive follow-up by the endocrinologist/diabetologist and dietitian to re-ceive an active dietary intervention plan, follow-up by the physiotherapist where sessions to start with physical exercise will be given. Monthly follow-up visits with the coordinating PCOS-midwife will be planned to enhance the subject's knowledge about PCOS and give emotional support. At the moment of randomization, the PCOS coordinating midwife will immediately plan all necessary appointments, with the endocrinologist and dietitian, physiotherapist and PCOS-coordinator, for the 12-week lifestyle program. This way, patients will have a clear overview of the following 12 weeks.

06

What researchers measure

Primary outcomes

  1. body weight

    body weight (kg)

    Time frame: 12 weeks after start of intervention

  2. body composition

    body composition (Total Body Fat and Fat Free Mass), measured by using bio-electric im-pedance analysis (BIA)

    Time frame: 12 weeks after start of intervention

07

Study locations

1 site
  • Universitair Ziekenhuis Brussel
    Brussel, 1090, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05084274
Lead sponsor
Universitair Ziekenhuis Brussel
Responsible party
Sponsor
First posted
Oct 19, 2021
Start date
Sep 10, 2021
Primary completion
Feb 26, 2024
Completion
Feb 26, 2024
Last update
Mar 15, 2024

Study contacts

Michel De Vos
principal investigator · Universitair Ziekenhuis Brussel

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion